Results 291 to 300 of about 3,988,826 (338)

Trends in the utilization, expenditure and costs of noninsulin glucose‐lowering drugs in the Medicaid population: Steady increases in glucagon‐like peptide‐1 receptor agonist and sodium–glucose transporter‐2 inhibitor use, prices and expenditure

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aims This study aimed to analyse changes in the utilization, expenditure and average cost of noninsulin glucose‐lowering drugs (GLDs) between 2008 and 2023. Methods This was a retrospective observational study of 2008–2023 data from the National Medicaid State Drug Utilization database.
Rawan O. Almadfaa
wiley   +1 more source

Socioeconomic status, antidepressant use, and return to work after disability due to common mental disorders. [PDF]

open access: yesEur Psychiatry
Leppänen H   +8 more
europepmc   +1 more source

Lifetime Socioeconomic Status, Cognitive Decline, and Brain Characteristics.

open access: yesJAMA Netw Open
Krueger KR   +8 more
europepmc   +1 more source

Measures of Socioeconomic Status

open access: yesCanadian Journal of Sociology / Cahiers canadiens de sociologie, 2021
G. Knight, M. Powers
semanticscholar   +2 more sources

Home - About - Disclaimer - Privacy